Matthew E. Spector, MD, FACS

Dr. Spector specializes in all aspects of extirpative head and neck surgical oncology and head and neck reconstruction. His research interests relate to both clinical and translational questions in head and neck oncology and head and neck reconstruction. He is primarily interested in improving the overall survival of patients with head and neck cancer through outcomes research to improve patient selection and prediction of response to therapy. He has significant experience in the design, management, and completion of biomarker-based experiments to assess predictors of recurrence in head and neck cancer.

He is a member of the American Head and Neck Society Mucosal Malignancies Section, Reconstructive Head and Neck Surgery Section, and the Salivary Gland Section. He is also a member of the Michigan Work Society, Triological Society, and American Head and Neck Society, and a Fellow, American College of Surgeons. He is a member of the Cancer Center Core, Head and Neck Oncology Research Program, committee lead for the Head and Neck Oncology Program Future Directions, and a member of the Otolaryngology Clinical Competency Committee. Additionally, he is a member of the Specialized Program of Research Excellence, Head and Neck Oncology Data Access Committee, Periprocedural Safety and Quality Improvement Program, and Cancer Strategic Planning Steering Committee. He is also a member of the Centralized Otolaryngology Research Effort (CORE) Committee. Dr. Spector is an editorial board member of Plastic and Aesthetic Research and Frontiers in Oncology.